O-0013KRAS/NRAS MUTATIONS IN PEAK: A RANDOMIZED PHASE 2 STUDY OF 1ST-LINE TREATMENT WITH FOLFOX6 + PANITUMUMAB OR BEVACIZUMAB FOR WILD-TYPE KRAS MCRC

作者： Fernando Rivera , Meinolf Karthaus , Gianpiero Fasola , Jean-Luc Canon , Lee Schwartzberg

DOI: 10.1093/ANNONC/MDT201.13

关键词: